Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Bone Therapeutics reports half year 2020 results

  • Read more about Bone Therapeutics reports half year 2020 results

Bone Therapeutics announces expansion of its pipeline supported by funding from the Walloon Region

  • Read more about Bone Therapeutics announces expansion of its pipeline supported by funding from the Walloon Region

Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

  • Read more about Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020

  • Read more about Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020

Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 8 February 2021

  • Read more about Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 8 February 2021

Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study

  • Read more about Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study

Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

  • Read more about Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook

  • Read more about Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook

Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 26 February 2021

  • Read more about Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 26 February 2021

Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference

  • Read more about Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions